This site uses cookies to collect statistics and improve your experience. By continuing to navigate you accept its use. View more


This project will commercialise novel and fast antibiotic susceptibility tests (AST) based on flow cytometric analysis, to determine antibiotic susceptibility of Gram-positive and Gram-negative bacteria. The novel flow cytometry microbial susceptibility FAST-bact test delivers very fast results (within 1h) when compared to the current state-of-the art AST methods that have a turnaround time of at least 24 hours.


The partners

  • +FASTinov S.A. (Portugal)
  • +μRoboptics (Portugal)
  • +Hospital Ramón y Cajal, part of SERMAS (Spain)
  • +EuroClone Diagnostica (Italy)
  • +Profess Medical Consultancy (Netherlands)

Recent News

view all news +
Funded by the Horizon 2020 framework programme of the European Union